Literature DB >> 3498962

Barrett's oesophagus: a clinical study of 52 patients.

B T Cooper1, G O Barbezat.   

Abstract

This paper reports a series of 52 patients with Barrett's (or columnar-lined) oesophagus from one medical unit diagnosed over a six-year period. The commonest associated symptoms were heartburn, regurgitation and dysphagia but 10 patients had no oesophageal symptoms and two had no symptoms at all. Gastrointestinal bleeding (overt or occult) was observed in almost one-third of patients. At diagnosis, 26 patients had oesophagitis, 23 had oesophageal ulceration and 10 had benign oesophageal strictures. An association between oesophageal ulceration and non-steroidal anti-inflammatory drug ingestion was suggested by the data and patients with oesophageal ulceration were significantly older than patients with uncomplicated Barrett's oesophagus. No patient had adenocarcinoma of the oesophagus at diagnosis and neither carcinoma nor dysplasia were seen during a mean period of 16.4 months. However, 17 per cent of patients in the series had malignancies in other sites. Most patients did well on medical treatment and only two were referred for anti-reflux surgery (both for non-healing oesophageal ulcers). Barrett's oesophagus was seen in 10 per cent of patients with gastro-oesophageal reflux at endoscopy. Oesophageal ulceration in patients with Barrett's oesophagus made up 21 per cent of oesophageal ulcers seen and benign oesophageal stricture in patients with Barrett's oesophagus constituted 13 per cent of all benign strictures seen. Barrett's oesophagus is common in our population and despite complications, it can be managed successfully, at least in the short term, by conservative means.

Entities:  

Mesh:

Year:  1987        PMID: 3498962

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  15 in total

Review 1.  Barrett's oesophagus--to screen or not to screen?

Authors:  M Atkinson
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.

Authors:  António Dias Pereira; Paula Chaves
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

3.  Benign oesophageal stricture in Barrett's oesophagus.

Authors:  B T Cooper
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

4.  Benign oesophageal stricture in Barrett's columnar epithelialised oesophagus and its responsiveness to conservative management.

Authors:  M Atkinson; C S Robertson
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

Review 5.  Epidemiology of gastro-esophageal reflux disease.

Authors:  P J Howard; R C Heading
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

6.  Associations between different forms of gastro-oesophageal reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

7.  Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.

Authors:  M Solaymani-Dodaran; R F A Logan; J West; T Card; C Coupland
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 8.  The gastroenterologist's approach to dysphagia.

Authors:  R Lorenz; G Jorysz; N Tornieporth; M Classen
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 9.  The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

Authors:  Eugene Y Chang; Cynthia D Morris; Ann K Seltman; Robert W O'Rourke; Benjamin K Chan; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

10.  Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.

Authors:  S Y Iftikhar; P D James; R J Steele; J D Hardcastle; M Atkinson
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.